Stockreport

I-Mab to Report Financial Results for Full Year 2019 and Provide Corporate Update on March 31, 2020

I-MAB - American Depositary Shares  (IMAB) 
PDF SHANGHAI, China and ROCKVILLE, MD., March 11, 2020 (GLOBE NEWSWIRE) -- I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to th [Read more]